Incidence of endometrioid and clear-cell ovarian cancer in histological proven endometriosis. The ENOCA population-based cohort study
Endometriosis
Related content
HPV and Gynecologic CancerEndometriosis
Ovarian cancer prognosis in women with endometriosis. A retrospective nationwide cohort study of 32,419 women
Am J Obstet Gynecol.
Hermens M, van Altena AM, van der Aa M, Bulten J, van Vliet HA, Siebers AG,
Bekkers RL
doi: 10.1016/j.ajog.
HPV and Gynecologic CancerReproductive Health
Histological subtypes of ovarian cancer associated with parity and breastfeeding in the prospective Million Women Study
Int J Cancer.
Gaitskell K, Green J, Pirie K, Barnes I, Hermon C, Reeves GK, Beral V; Million Women Study Collaborators
doi: 10.1002/ijc.31063.
Reproductive Health
Predicting acute ovarian failure in female survivors of childhood cancer: a cohort study in the Childhood Cancer Survivor Study (CCSS) and the St Jude Lifetime Cohort (SJLIFE)
Lancet Oncol.
Clark RA, Mostoufi-Moab S, Yasui Y, Vu NK, Sklar CA, Motan T, Brooke RJ, Gibson TM, Oeffinger KC, Howell RM, Smith SA, Lu Z, Robison LL, Chemaitilly W, Hudson MM, Armstrong GT, Nathan PC, Yuan Y
doi: 10.1016/S1470-2045(19)30818-6.
HPV and Gynecologic Cancer
No survival difference between robotic and open radical hysterectomy for women with early-stage cervical cancer: results from a nationwide population-based cohort study
Eur J Cancer.
Alfonzo E, Wallin E, Ekdahl L, Staf C, Rådestad AF, Reynisson P, Stålberg K, Falconer H, Persson J, Dahm-Kähler P
doi: 10.1016/j.ejca.
The risk of breast and gynecological cancer in women with a diagnosis of infertility: a nationwide population-based study
Eur J Epidemiol.
Lundberg FE, Iliadou AN, Rodriguez-Wallberg K, Gemzell-Danielsson K, Johansson ALV
doi: 10.1007/s10654-
HPV and Gynecologic Cancer
Prevalence of genetic susceptibility for breast and ovarian cancer in a non-cancer related study population: secondary germline findings from a Swiss single centre cohort
Swiss Med Wkly.
Kraemer D, Azzarello-Burri S, Steindl K, Boonsawat P, Zweier M, Dedes KJ, Joset P, Fink D, Rauch A
doi: 10.4414/smw.2019.20092.
HPV and Gynecologic Cancer
Ovarian cancer risk factor associations by primary anatomic site: the Ovarian Cancer Cohort Consortium
Cancer Epidemiol Biomarkers Prev.
Fortner RT, Rice MS, Knutsen SF, Orlich MJ, Visvanathan K, Patel AV, Gaudet MM, Tjonneland A, Kvaskoff M, Kaaks R, Trichopoulou A, Pala V, Onland-Moret NC, Gram IT, Amiano P, Idahl A, Allen NE, Weiderpass E, Poynter JN, Robien K, Giles GG, Milne RL, Setiawan VW, Merritt MA, van den Brandt PA, Zeleniuch-Jacquotte A, Arslan AA, O'Brien KM, Sandler DP, Wolk A, Håkansson N, Harris HR, Trabert B, Wentzensen N, Tworoger SS, Schouten LJ
doi: 10.1158/1055-9965.EPI-20-0354.
HPV and Gynecologic Cancer
Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers
Cancer Epidemiol Biomarkers Prev.
Glubb DM, Thompson DJ, Aben KK, Alsulimani A, Amant F, Annibali D, Attia J, Barricarte A, Beckmann MW, Berchuck A, Bermisheva M, Bernardini MQ, Bischof K, Bjørge L, Bodelon C, Brand AH, Brenton JD, Brinton LA, Bruinsma F, Buchanan DD, Burghaus S, Bützow R, Cai H, Carney ME, Chanock SJ, Chen C, Chen X, Chen Z, Cook LS, Cunningham JM, De Vivo I, DeFazio A, Doherty JA, Dork T, du Bois A, Dunning AM, Durst M, Edwards T, Edwards RP, Ekici AB, Ewing A, Fasching PA, Ferguson S, Flanagan JM, Fostira F, Fountzilas G, Friedenreich CM, Gao B, Gaudet MM, Gawełko J, Gentry-Maharaj A, Giles GG, Glasspool R, Goodman MT, Gronwald J, Harris HR, Harter P, Hein A, Heitz F, Hildebrandt MAT, Hillemanns P, Høgdall E, Høgdall CK, Holliday EG, Huntsman DG, Huzarski T, Jakubowska A, Jensen A, Jones ME, Karlan BY, Karnezis A, Kelley JL, Khusnutdinova E, Killeen JL, Kjaer SK, Klapdor R, Köbel M, Konopka B, Konstantopoulou I, Kopperud RK, Koti M, Kraft P, Kupryjanczyk J, Lambrechts D, Larson MC, Le Marchand L, Lele S, Lester J, Li AJ, Liang D, Liebrich C, Lipworth L, Lissowska J, Lu L, Lu KH, Macciotta A, Mattiello A, May T, McAlpine JN, McGuire V, McNeish IA, Menon U, Modugno F, Moysich KB, Nevanlinna H, Odunsi K, Olsson H, Orsulic S, Osorio A, Palli D, Park-Simon TW, Pearce CL, Pejovic T, Permuth JB, Podgorska A, Ramus SJ, Rebbeck TR, Riggan MJ, Risch HA, Rothstein JH, Runnebaum IB, Scott RJ, Sellers TA, Senz J, Setiawan VW, Siddiqui N, Sieh W, Spiewankiewicz B, Sutphen R, Swerdlow AJ, Szafron LM, Teo SH, Thompson PJ, Thomsen LCV, Titus L, Tone A, Tumino R, Turman C, Vanderstichele A, Velez Edwards D, Vergote I, Vierkant RA, Wang Z, Wang-Gohrke S, Webb PM, White E, Whittemore AS, Winham SJ, Wu X, Wu AH, Yannoukakos D, Spurdle AB, O'Mara TA
doi: 10.1158/1055-9965.EPI-20-0739.
Uro-Oncology
The deleterious association between proton pump inhibitors and prostate cancer-specific mortality - a population-based cohort study
Prostate Cancer Prostatic Dis.
Goldberg H, Mohsin FK, Saskin R, Kulkarni GS, Berlin A, Kenk M, Wallis CJD, Chandrasekar T, Klaassen Z, Saarela O, Penn L, Alibhai SMH, Fleshner N
doi: 10.1038/s41391-020-0248-9.